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Abstract
Objective—Barrett’s oesophagus is a precursor lesion of oesophageal adenocarcinoma, a cancer
that, in the USA, has increased in incidence over 600% during the past 40 years. Barrett’s
oesophagus and oesophageal adenocarcinoma are much more common among men than among
women; this finding is unexplained and most earlier studies lacked sufficient numbers of women
to evaluate sex-specific risk factors. We leveraged the power of an international consortium to
assess sex-specific relationships between body mass index (BMI), abdominal circumference and
Barrett’s oesophagus.
Design—Four case–control studies provided a total of 1102 cases (316 women, 786 men) and
1400 population controls (436 women, 964 men) for analysis. Study-specific estimates, generated
using individual participant data, were combined using random effects meta-analysis.
Results—Waist circumference was significantly associated with Barrett’s oesophagus, even after
adjustment for BMI; persons in the highest versus the lowest quartiles of waist circumference had
approximately 125% and 275% increases in the odds of Barrett’s oesophagus among men and
women, respectively (OR 2.24, 95% CI 1.08 to 4.65, I2=57; OR 3.75, 95% CI 1.47 to 9.56, I2=0).
In contrast, there was no evidence of a significant association between BMI and the risk of
Barrett’s oesophagus, with or without adjustment for waist circumference.
Conclusions—Waist circumference, independent of BMI, was found to be a risk factor for
Barrett’s oesophagus among both men and women. Future studies examining the biological
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mechanisms of this association will extend our knowledge regarding the pathogenesis of Barrett’s
oesophagus.
BACKGROUND
Barrett’s oesophagus is a precursor to oesophageal adenocarcinoma, a cancer that has
undergone a rapid increase in incidence (over 600%) during the past four decades.1–4
Approximately 10% of adult Americans over the age of 50 years with gastroesophageal
reflux disease (GERD) are predicted to harbour Barrett’s oesophagus,5 and the US
prevalence may be as high as 3 million individuals.6 The importance of Barrett’s
oesophagus relates to its potential for neoplastic progression into oesophageal
adenocarcinoma;7–9 its presence is associated with a 10–40-fold increased risk of
oesophageal adenocarcinoma (approximately one in 200 person-years) compared with the
general population.710–13
Barrett’s oesophagus is approximately twice as prevalent among men as women, and five
times as prevalent among Caucasian as African-American individuals.14 As the most well-
known risk factor for Barrett’s oesophagus, GERD symptoms, is not markedly differentially
distributed by race or sex,15 increasing attention has been paid to obesity as a risk factor for
Barrett’s oesophagus, particularly because of the parallel increases in obesity and the
incidence of oesophageal adenocarcinoma and Barrett’s oesophagus. General obesity, often
measured using the proxy body mass index (BMI), and abdominal obesity have been fairly
consistently associated with the risk of oesophageal adenocarcinoma.16–21 However,
associations between BMI and Barrett’s oesophagus have been inconsistent.172223 On the
other hand, abdominal obesity, measured as waist circumference or visceral adipose tissue,
appears to be more consistently associated with Barrett’s oesophagus.1418–21 Abdominal
obesity is more common among men than women;24 however, individual studies of Barrett’s
oesophagus have lacked the ability to evaluate sex-specific associations of obesity, the effect
of abdominal obesity independent of BMI, and/or the interaction between obesity and
GERD—all in relation to this premalignant metaplasia.17222526
The investigation of sex-specific differences in risk factors of Barrett’s oesophagus may
help explain the marked differences in demographic distributions of these disorders and
provide potential targets for intervention and/or further investigation. Previous studies were
unable to evaluate risk factors stratified by sex due to insufficient numbers of women in
study populations. We took advantage of a large international consortium of Barrett’s
oesophagus case–control studies—the Barrett’s and Esophageal Adenocarcinoma
Consortium (BEACON, http://beacon.tlvnet.net/). We investigated the sex differences in the
relationships between obesity, abdominal obesity and Barrett’s oesophagus and assessed
whether these relationships were modified by GERD and cigarette smoking.
MATERIALS AND METHODS
BEACON consortium
BEACON was formed in 2005 by an international group of investigators in collaboration
with the US National Cancer Institute. The consortium consists of completed or ongoing
case–control and cohort studies of oesophageal adenocarcinoma and/or Barrett’s
oesophagus, and its primary aim is to provide an open scientific forum for epidemiological
research into the aetiology and prevention of these diseases by facilitating the sharing of
data across population-based studies. Therefore, rather than relying on a meta-analytical
approach of published risk estimates, which often have different variable definitions and
statistical models, BEACON enables pooled analyses of individual participant data from
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population-based studies using a standard model, after harmonisation of variable definitions
and common confounders.
Study population
The present analysis used data from four case–control studies within BEACON: the
FINBAR (Factors Influencing the Barrett’s/ Adenocarcinoma Relationship) study, based in
Ireland;16 the Epidemiology and Incidence of Barrett’s Oesophagus, based in the Kaiser
Permanente Northern California population, USA;25 the Study of Reflux Disease based in
western Washington state, USA;26 and the Study of Digestive Health, based in Brisbane,
Australia.17 Cases were compared with population-based controls that represented the
source population from which the Barrett’s oesophagus cases arose. The original studies and
the current data pooling were approved by the institutional review board or research ethics
committee of each sponsoring institution.
Study variables
Exposure variables used for this analysis were: BMI (weight (kg) divided by square of
height (m)) and waist circumference (cm). The waist–hip ratio was also available from three
studies, but given its high correlation with waist circumference (r=0.73 in the combined
population control dataset), our analyses focus on BMI and waist circumference. All
anthropometric measures were taken in-person using study-specific protocols. In the
Brisbane study, waist circumference data were available only for a subset of the case (61%)
and population-based control groups (38%).
For analyses, BMI was categorised into an ordinal variable with four groups based on WHO
criteria:27 healthy (BMI 18.5–24.9), overweight (BMI 25–29.9), obese class I (BMI 30–
34.9), and obese class II+ (BMI 35+). We evaluated the association between abdominal
adiposity and Barrett’s oesophagus by assessment of the exposure waist circumference. We
further conducted analyses including both BMI and waist circumference in the model: this
effectively compares differences in waist circumference among persons within the same
BMI, and differences in BMI among persons within the same waist circumference. We
created quartile categories for waist circumference based on a sex-specific population-based
control group. We also assessed BMI and waist circumference continuously to assess the
dose–effect relationship. The proportions of individuals with abdominal obesity among
cases and controls were also compared using cut-off points defined by the National Heart,
Lung, and Blood Institute, American Heart Association and International Diabetes
Federation28 (>102 cm for men, >88 cm for women).
Covariates were measured using questionnaires; variables assessed for inclusion in
regression models were: calories per day; alcohol (drinks per day); vegetables and fruit
servings per day; vitamin supplement use; self-reported GERD symptoms (frequency of
heartburn and regurgitation); Helicobacter pylori seropositivity; and the use of non-steroidal
anti-inflammatory drugs. A covariate was retained in the fully adjusted models if it altered
the summary estimate by more than 10% or it was considered a known potential confounder
(age, sex, smoking and education).
Statistical methods
The analyses used a two-step approach. First, we used multivariable logistic regression
models to obtain study-specific OR and 95% CI of the association between each exposure
and Barrett’s oesophagus within each study. Second, to pool the study-specific OR, we used
both fixed effects and random effects meta-analytical models to generate summary OR.
Because these two models provided essentially identical results, we only show the results for
the random effects models, which generally provide more conservative summary OR.29 We
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used the I2 statistic21 to examine heterogeneity. The I2 statistic estimates the percentage of
total variation across studies due to heterogeneity. An I2 statistic of 0% indicates no
heterogeneity that cannot be attributed to chance, whereas larger values indicate increasing
heterogeneity beyond chance: I2 of 25%, 50% and 75% are generally considered low,
moderate and high levels of heterogeneity, respectively.30
We conducted analyses stratified by sex, as well as men and women combined. Referent
categories in categorical analyses were 18.5–24.9 for BMI and the first quartile for waist
circumference. We evaluated continuous variables to test for linear trend by using OR per
unit BMI and per 5 cm waist circumference. Models that compared cases with population-
based controls were further adjusted for self-reported GERD symptoms (ordinal variable:
either heartburn or regurgitation never; less than once a week; weekly; more than weekly
and less than daily; and more than daily) to evaluate potential confounding effects of GERD
symptoms. All models were adjusted for age (<50, 50–59, 60+ years); sex (when men and
women were combined); race (white vs non-white); cigarette smoking (pack-years);
harmonised education (school only, tech/diploma, university).
To assess for effect-measure modification, the models were stratified by cigarette smoking
(ever vs never) and GERD symptoms (weekly or more heartburn or regurgitation vs less
than weekly). The likelihood ratio test was conducted to assess the significance of effect-
measure modification by these variables using a pooled dataset of all four studies with
adjustment for age, study, smoking, education, BMI and waist circumference (mutual
adjustment). The full (saturated) model also included a cross-product term between the
categorical anthropometric variable (BMI or waist circumference) and either the
dichotomous cigarette smoking exposure (ever vs never) or the ordinal GERD symptom
variable (never vs weekly or more).
Two-sided p values less than 0.05 were considered statistically significant. All analyses
were conducted using STATA 10.1.
RESULTS
Participant characteristics
Detailed descriptions of recruitment procedures and study definitions for cases and controls
have been described previously.31 A total of 1130 subjects with Barrett’s oesophagus (cases)
and 1434 population controls from the four case–control studies were available for pooling.
We excluded subjects for whom either height or weight were missing (10 cases; 17
population controls). We also excluded subjects with unlikely anthropometric data (ie, waist
circumference <50 cm and BMI >20: two cases; four population controls) and individuals
with a BMI less than 18.5 (16 cases; 13 population controls). After exclusions, there
remained 1102 Barrett’s oesophagus cases and 1400 population-based controls for analysis
(table 1).
Cases were more likely than controls to be current or former smokers and to have more
frequent GERD symptoms, for both men and women (table 2). A higher mean waist
circumference, but not mean BMI, was also more common among cases than controls, for
both men and women.
Pooled analyses
Body mass index—When compared with population-based controls, male subjects with a
BMI of 30–34.9 were slightly more likely to have Barrett’s oesophagus than subjects with a
BMI of 18.5–24.9, although no consistent pattern was observed in the association between
increasing BMI and Barrett’s oesophagus (see supplementary table S1, available online
Kubo et al. Page 4













only). For instance, the OR for each BMI category for men were: OR>25–29.9 1.05 (95% CI
0.82 to 1.34, I2=0%); OR>30–34.9 1.37 (95% CI 1.01 to 1.86, I2=8%); OR≥35 1.10 (95% CI
0.74 to 1.66, I2=0%) (model 1). No significant associations were found between BMI and
Barrett’s oesophagus among women and these analyses had evidence of at least moderate
heterogeneity (per unit increase in BMI, OR 1.02, 95% CI 0.98 to 1.07, I2=52%). When the
model was adjusted for self-reported GERD symptoms, the effect estimates were very
slightly attenuated for men, women and combined analyses (model 2, table 3). When the
model was adjusted for waist circumference (table 3), the associations attenuated, and most
of the OR became close to 1.
Waist circumference—Table 4 presents the results of the association between waist
circumference and Barrett’s oesophagus adjusting for BMI, which effectively estimates the
effect of waist circumference on the risk of Barrett’s oesophagus among persons with the
same BMI. The risk of Barrett’s oesophagus increased with larger waist circumferences. For
instance, being in the highest quartile of waist circumference was associated with
approximately a 125% and 275% increase in the risk of Barrett’s oesophagus among men
and women, respectively (OR 2.24, 95% CI 1.08 to 4.65, I2=57; OR 3.75, 95% CI 1.47 to
9.56, I2=0, respectively). When the waist circumference variable was analysed continuously,
there was a trend towards statistical significance for both men and women (p=0.07). When
the model was further adjusted for GERD symptoms (table 4, model 2), the associations
remained significant among men while among women the 95% CI were wide and included
1. When men and women were combined, using sex-specific quartile cut points, there were
strong dose–effect associations in models with or without adjustment for GERD (p=0.03 and
p=0.01, respectively).
When the models were not adjusted for BMI (see supplementary table S1, available online
only), similar associations were observed, although the associations were slightly weaker
than the model adjusted for BMI (table 4). For instance, being in the highest quartile of
waist circumference was associated with an approximately 60% and 180% increase in the
risk of Barrett’s oesophagus among men and women (OR 1.62, 95% CI 1.09 to 2.41, I2=34;
OR 2.80, 95% CI 1.39 to 5.64, I2=25, respectively). There was a significant dose–effect
association among men (p=0.05) and a trend towards a significant association for women
(p=0.08).
Waist to hip ratio—We also conducted an analysis examining the association between
waist to hip ratio and Barrett’s oesophagus (see supplementary table S4, available online
only). Due to skewed distribution in the waist to hip ratio in one study in which no woman
was in the lowest quartile, we used the second quartile as referent. Overall, the waist to hip
ratio was associated with the risk of Barrett’s oesophagus, particularly among men. Being in
the first quartile of the waist to hip ratio was associated with half the risk of Barrett’s
oesophagus (OR 0.44, 95% CI 0.29 to 0.67, I2=0), although for the third and fourth quartiles
the associations were non-significant (OR 0.96, 95% CI 0.66 to 1.40; OR 1.07, 95% CI 0.60
to 1.91, respectively). For women there were no associations between the waist to hip ratio
and Barrett’s oesophagus (data not shown).
Supplementary analyses
Effect-modification (stratified analyses) by smoking and GERD symptoms—
The associations between BMI or waist circumference and Barrett’s oesophagus were
similar among male smokers versus non-smokers and among persons with versus without
GERD symptoms (see supplementary table 3, available online only). These models were
adjusted for age, race, education, pack-years of cigarette smoking, BMI and waist
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circumference (mutual adjustment). Among women, we were unable to assess effectmeasure
modification due to the smaller sample size.
Exploration of heterogeneity—The associations between waist circumference and
Barrett’s oesophagus results were fairly homogeneous (tables 2 and 3; see also Forrest plots,
figures 1A,B). For BMI analyses (unadjusted for waist circumference), there was evidence
of moderate to high heterogeneity among women (table 3). This heterogeneity was mainly
driven by the low effect estimates from the FINBAR study. The FINBAR study also did not
have any women who were in the highest BMI category. When the FINBAR study was
excluded, I2 were reduced to 0% and 11% for the second and third BMI categories, and the
effect estimates were strengthened: OR>25–29.9 1.97 (95% CI 1.31 to 2.96, I2=0%);
OR≥30–34.9 1.73 (95% CI 1.05 to 2.87, I2=11%), although the effect estimate was unchanged
for the highest BMI category (see supplementary figure S1, available online only).
DISCUSSION
This is the first study to evaluate the sex-specific associations between BMI, waist
circumference and the risk of Barrett’s oesophagus within a large population-based sample.
There are several findings. First, the study demonstrated that there is no association between
BMI and the risk of Barrett’s oesophagus. Second, abdominal obesity is significantly
associated with the risk of Barrett’s oesophagus in both men and women. Finally, the
association between waist circumference and Barrett’s oesophagus strengthened when the
model was adjusted for BMI.
Our results demonstrate that abdominal obesity is a strong predictor of Barrett’s oesophagus,
independent of BMI. This suggests that previous studies that reported associations between
BMI alone and Barrett’s oesophagus were likely to have been confounded by unmeasured
abdominal obesity. Previous studies have also been limited in their capacity to stratify data
by sex. The BEACON consortium, which takes advantage of pooling studies of Barrett’s
oesophagus and oesophageal adenocarcinoma, both of which are relatively uncommon in
women compared with men, enabled us to assemble a large sample size of Barrett’s
oesophagus subjects from four independent case–control studies. Our analyses suggest that
increasing waist circumference is associated with the risk of Barrett’s oesophagus among
both men and women, therefore the strengths of sex-specific association alone do not
explain the sex disparities in the incidence of Barrett’s oesophagus. However, men,
particularly of white race, tend to accumulate visceral (abdominal) fat more than women; a
recent study using the National Health and Nutrition Examination Survey data showed that
the prevalence of abdominal obesity was higher among men and white individuals than
women and other racial/ethnic subgroups.24 Therefore, we cannot exclude the possibility
that the greater prevalence of abdominal obesity among men than women, may, at least
partly explain the observed sex disparities in the incidence of Barrett’s oesophagus.
It remains unclear how abdominal obesity increases the risk of Barrett’s oesophagus. It has
been hypothesised that abdominal obesity may induce GERD through mechanical
mechanisms via increased abdominal pressure, which subsequently relaxes the lower
oesophageal sphincter, exposing the lower oesophagus to gastric acid, resulting in an
increase in the risk of GERD and thus Barrett’s oesophagus.32–34 Although the present
analysis found some attenuation of the association between waist circumference and
Barrett’s oesophagus when using populationbased controls with adjustment for GERD
symptoms, a positive association persisted when the model was adjusted for BMI and
GERD symptoms. These results suggest that the mechanism is more complex and that there
are other pathways besides GERD through which abdominal obesity affects the aetiology of
Barrett’s oesophagus. For instance, the risk of developing insulin resistance and metabolic
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syndrome is higher in individuals with visceral (abdominal) obesity than in those with
subcutaneous obesity.35 Insulin resistance and metabolic syndrome are associated with
several cancers;36–42 such metabolic dysregulation may mediate the association between
abdominal obesity and the carcinogenesis process of oesophageal adenocarcinoma. In
addition, visceral fat is associated with particular metabolic compounds and a different
balance of adipose-related hormones including insulin-like growth factor, tumour necrosis
factor α, interleukin 6, and adipokines (eg, leptin, adiponectin), many of which have also
been found to be linked to the carcinogenesis processes of other cancers and with
mechanisms of healing and injury to gastrointestinal mucosal surfaces.3643–47 Future studies
that investigate the effects of adipose-related hormones will extend our knowledge regarding
the pathogenesis of Barrett’s oesophagus.
There were several strengths of this study. First, this study pooled individual participant data
through a large international consortium; this method provides more comparable statistical
estimates than standard meta-analyses, which pool published OR that differ in their variable
definitions and in their inclusion of potential confounding variables. Therefore, the results of
this analysis are the strongest available data to date regarding obesity and abdominal obesity
as risk factors for Barrett’s oesophagus. Its large sample size also provided additional
statistical power to investigate sex-specific associations between obesity and Barrett’s
oesophagus as well as an assessment of effect-measure modification. Second, the data were
of high quality. Anthropometric measurements used trained personnel in all studies, rather
than self-report, avoiding measurement and recall biases, and other variables were obtained
through direct interviews or questionnaires.
There are a few limitations of this study. First, observational studies cannot definitively
establish cause and effect,48 and are subject to confounding by other unmeasured variables.
Although analyses that evaluated all the measured potential confounders provided little
evidence of confounding, we cannot exclude the possibility that some measured or
unmeasured factors might have influenced the results. Third, there is a difference between
self-reported GERD symptoms and the actual amount of acid reflux; thus analyses adjusting
for GERD symptoms do not fully adjust for the presence of reflux. Fourth, there was
evidence of moderate levels of heterogeneity for some analyses, specifically for the analysis
of BMI among women. The heterogeneity decreased and effect estimates strengthened when
the FINBAR study was excluded. It is unclear why the associations between BMI and
Barrett’s oesophagus were lower in this Irish study population. The cases included only
persons with long-segment (>3 cm) Barrett’s oesophagus and we observed unusual
distributions of BMI and waist to hip ratio in this population; there were no female
population controls who were in the BMI greater than 35 or the first quartile waist to hip
ratio categories in this study. However, the proportion of normal weight individuals among
FINBAR was equivalent to the average of all studies, and it does not explain why this study
produced low estimates of the association between obesity and Barrett’s oesophagus. The
heterogeneity may also be partly explained by their matching method, which differed from
all other studies: the FINBAR study matched the controls to their oesophageal
adenocarcinoma cases rather than Barrett’s oesophagus cases, although any of this effect
should have been lessened by adjustment for the matching factors in this analysis.
In conclusion, abdominal obesity is a risk factor for Barrett’s oesophagus among both men
and women, independent of BMI; individuals with higher waist circumferences were at a
1.5–2.8-fold increased risk of having Barrett’s oesophagus among general populations.
Future studies examining the biological mechanisms of this association will extend our
knowledge regarding the pathogenesis of Barrett’s oesophagus.
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Significance of this study
What is already known on this subject?
► Incidence rates of Barrett’s oesophagus and oesophageal adenocarcinoma
have increased rapidly over the past few decades, while the reasons for such
are poorly understood.
► Men, white individuals, and those with gastroesophageal reflux are at a
higher risk of Barrett’s oesophagus and oesophageal adenocarcinoma, but
these factors alone do not explain the rise in incidence.
► Obesity has been thought to increase the risk of Barrett’s oesophagus but
little is known as to whether BMI or abdominal obesity is the effector of this
relationship.
What are the new findings?
► Our finding suggests that increasing abdominal obesity, not BMI, increases
the risk of Barrett’s oesophagus.
► Similar associations were observed for both men and women.
► The association was not altered when adjusted for symptoms of GERD.
How might it impact on clinical practice in the foreseeable future?
► Future research examining biomarkers can lead to the identification of high-
risk populations for closer monitoring of the progression to cancer.
► Among a high-risk population (male, white, GERD symptoms), interventions
to reduce abdominal obesity may help prevent the occurrence of Barrett’s
oesophagus.
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Forrest plots of the relationship between quartiles of waist circumference and Barrett’s
oesophagus for men (a) and women (b). (a) Men, model was adjusted for age (categorical),
race, education, smoking (pack-years) and body mass index (BMI) (continuous). (b)
Women, model was adjusted for age (categorical), race, education, smoking (pack-years)
and BMI (continuous).
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Table 1
Characteristics of the individual studies included in this pooled analysis





The FINBAR study Northern Ireland and Republic of
Ireland
2002–2004 (183/37) (218/40)
Kaiser Permanente Northern California, USA 2002–2005 (230/84) (209/102)
Washington state Washington, USA 1997–2000 (117/73) (130/74)
Study of Digestive
Health
Brisbane, Queensland, Austraia 2003–2006 (256/122) (407/220)
FINBAR, Factors Influencing the Barrett’s/Adenocarcinoma Relationship.
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